1889-836X
1889-836X
S1889-836X2023000300004
10.20960/revosteoporosmetabminer.00013
España
España
España
España
España
00
09
2023
00
09
2023
15
3
115
124
[
2016
594
8
8
2001-24
]
[
United Nations
2019
]
[
2020
45
7
7
578-92
]
[
2020
16
5
5
263-75
]
[
2013
123
3
3
966-72
]
[
2020
226
]
[
2016
71
11
11
1407-14
]
[
2014
159
4
4
709-13
]
[
2013
153
6
6
1194-217
]
[
2020
288
5
5
518-36
]
[
1961
25
585-621
]
[
2020
]
[
2019
121
121-33
]
[
2018
28
6
6
436-53
]
[
2014
31
6
6
722-33
]
[
2021
171
169-90
]
[
2021
106
3
3
e1481-7
]
[
2022
1507
1
1
70-83
]
[
2017
21
21-8
]
[
2019
179
4
4
813-27
]
[
2015
14
4
4
644-58
]
[
2017
65
10
10
2297-301
]
[
2017
72
6
6
780-5
]
[
2011
479
7372
7372
232-6
]
[
2018
103
4
4
]
[
2017
23
9
9
1072-9
]
[
2010
70
22
22
9381-90
]
[
2004
91
5
5
399-402
]
[
2019
19
8
8
439-53
]
[
2019
42
12
12
]
[
2017
8
1
1
]
[
2017
9
3
3
955-63
]
[
2018
36
18-28
]
[
2016
15
3
3
428-35
]
[
2016
22
1
1
78-83
]
[
2016
8
11
11
2915-26
]
[
2017
169
1
1
132.e16-47.e16
]
[
2019
62
10
10
1835-41
]
[
2016
31
11
11
]
[
2015
112
46
46
E6301-10
]
[
2016
34
3
3
756-67
]
[
HORIZON Recurrent Fracture Trial
2007
357
18
18
1799-809
]
[
2020
141
]
[
2020
35
1
1
20-7
]
[
2014
29
6
6
1311-21
]
[
2018
33
2
2
199-210
]
[
2018
379
25
25
]
[
2018
24
8
8
]
[
2021
288
2
2
56-80
]
[
2022
21
]